Evidence map›Paper›PMID 40911304›Full record

ArticleJournal of clinical microbiology2025

Standardized surveillance of blood culture contamination rates: moving toward a universal standard.

Fizza Manzoor, Sarah E Turbett

Abstract readComment
In one paragraph

Article in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Fizza ManzoorDivision of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Sarah E TurbettDivision of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-3603-8110

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood culture contamination (BCC) is a major healthcare challenge with no standardized process to monitor and report rates by individual healthcare facilities in the United States. A new study by V. Fabre, Y.- J. Hsu, K. C. Caroll, A. M. Milstone, et al. (J Clin Microbiol 63:e0053025, 2025, https://doi.org/10.1128/jcm.00530-25) characterizes blood culture contamination rates, surveillance methods, reporting practices, and preventative strategies across 52 centers in the United States. The study highlights a need for standardized surveillance metrics and target thresholds within and across hospitals to help facilitate accurate benchmarking, provide feedback on existing processes, support antimicrobial and diagnostic stewardship efforts, and allocate resources to reduce BCC events.

Indexed as

Blood CultureHospitalsHumansUnited States

Identifiers

PMID40911304
PMCPMC12506060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.